A randomized, double-blind, placebo-controlled efficacy and safety study of bifeprunox as treatment for patients with acutely exacerbated schizophrenia

被引：0
|
作者：
Meltzer, H. [1 ]
Barbato, L. M. [1 ]
Heisterberg, J. [1 ]
Yeung, P. P. [1 ]
Shapira, N. A. [1 ]
机构：
[1] Vanderbilt Univ, Ctr Med, Psychopharmacol Div, Nashville, TN 37232 USA
来源：
SCHIZOPHRENIA BULLETIN | 2007年 / 33卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：446 / 446
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of lurasidone in acutely psychotic patients with schizophrenia: A 6-week, randomized, double-blind, placebo-controlled study
    Iyo, Masaomi
    Ishigooka, Jun
    Nakamura, Masatoshi
    Sakaguchi, Reiko
    Okamoto, Keisuke
    Mao, Yongcai
    Tsai, Joyce
    Fitzgerald, Alison
    Nosaka, Tadashi
    Higuchi, Teruhiko
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2021, : 227 - 235
  • [2] Efficacy and safety of lurasidone in acutely psychotic patients with schizophrenia: A 6-week, randomized, double-blind, placebo-controlled study
    Iyo, Masaomi
    Ishigooka, Jun
    Nakamura, Masatoshi
    Sakaguchi, Reiko
    Okamoto, Keisuke
    Mao, Yongcai
    Tsai, Joyce
    Fitzgerald, Alison
    Nosaka, Tadashi
    Higuchi, Teruhiko
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2021, 75 (07) : 227 - 235
  • [3] Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study
    Daniel E. Casey
    Earl E. Sands
    Jens Heisterberg
    Hwa-Ming Yang
    Psychopharmacology, 2008, 200 : 317 - 331
  • [4] Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study
    Casey, Daniel E.
    Sands, Earl E.
    Heisterberg, Jens
    Yang, Hwa-Ming
    PSYCHOPHARMACOLOGY, 2008, 200 (03) : 317 - 331
  • [5] SAFETY AND EFFICACY OF KARXT IN PATIENTS WITH SCHIZOPHRENIA IN THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED EMERGENT TRIALS
    Kramer, Kenneth
    Brannan, Stephen K.
    Sauder, Colin
    Kaul, Inder
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : i162 - i162
  • [6] Efficacy and Safety of Loxapine for Inhalation in the Treatment of Agitation in Patients With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Allen, Michael H.
    Feifel, David
    Lesem, Michael D.
    Zimbroff, Daniel L.
    Ross, Ruth
    Munzar, Patrik
    Spyker, Daniel A.
    Cassella, James V.
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (10) : 1313 - 1321
  • [7] Efficacy and safety of paliperidone palmitate in adult patients with acutely symptomatic schizophrenia: a randomized, double-blind, placebo-controlled, dose-response study
    Gopal, Srihari
    Hough, David W.
    Xu, Haiyan
    Lull, Julia M.
    Gassmann-Mayer, Cristiana
    Remmerie, Bart M.
    Eerdekens, Marielle H.
    Brown, David W.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2010, 25 (05) : 247 - 256
  • [8] Randomized, placebo-controlled, double-blind study assessing the efficacy and safety of paliperidone palmitate in Asian patients with schizophrenia
    Takahashi, Nagahide
    Takahashi, Masayoshi
    Saito, Takayuki
    Iizumi, Misuzu
    Saito, Yuki
    Shimizu, Hiroko
    Matsumura, Taka
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 1889 - 1897
  • [9] A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia
    Tandon, R.
    Loebel, A.
    Phillips, D.
    Pikalov, A.
    Hernandez, D.
    Mao, Y.
    Cucchiaro, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 153 - 154
  • [10] A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL STUDY OF LURASIDONE FOR THE MAINTENANCE OF EFFICACY IN PATIENTS WITH SCHIZOPHRENIA
    Tandon, R.
    Loebel, A.
    Phillips, D.
    Pikalov, A.
    Hernandez, D.
    Mao, Y.
    Cucchiaro, J.
    EUROPEAN PSYCHIATRY, 2014, 29
12345